- Report
- June 2025
- 200 Pages
Global
From €2211EUR$2,490USD£1,932GBP
- Report
- November 2025
- 183 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- November 2025
- 197 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- October 2025
- 184 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- October 2025
- 196 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- October 2025
- 197 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- August 2025
- 187 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- November 2025
- 188 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- November 2025
- 182 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- October 2025
- 190 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- December 2025
- 388 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 377 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 270 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 284 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 184 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 311 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 189 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 177 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 188 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 193 Pages
Global
From €5196EUR$5,850USD£4,540GBP

The Ventricular Assist Device (VAD) market is a subset of the Cardiovascular Devices market. VADs are mechanical pumps that are implanted in the body to help the heart pump blood. They are used to treat heart failure, bridge patients to heart transplantation, and provide long-term support for patients with end-stage heart failure. VADs are typically used in patients who are not eligible for heart transplantation or who are waiting for a donor heart.
VADs are classified into two main categories: left ventricular assist devices (LVADs) and right ventricular assist devices (RVADs). LVADs are used to support the left ventricle, while RVADs are used to support the right ventricle. Both types of VADs are designed to improve the quality of life of patients with heart failure.
Some companies in the VAD market include Abiomed, Medtronic, Thoratec, and SynCardia. Show Less Read more